E'Twaun Moore
PHX
GAge 32Last season rank #359
Turnovers per game — 20-21, league-wide. Lower is better.
League Leader0.1
This Player0.9
League Average1.3
Ranking Trend
Lower rank is better.
Full data
| Season | Rank |
|---|---|
| 11-12 | n/a |
| 12-13 | #246 |
| 13-14 | #246 |
| 14-15 | n/a |
| 15-16 | #222 |
| 16-17 | #170 |
| 17-18 | #110 |
| 18-19 | #174 |
| 19-20 | #303 |
| 20-21 | #359 |
Stat Trend
Track role, durability, and category growth by season. Scoring: 9-category
PTS
Full data
| Season | PTS |
|---|---|
| 11-12 | 2.9 |
| 12-13 | 7.8 |
| 13-14 | 6.3 |
| 14-15 | 2.7 |
| 15-16 | 7.5 |
| 16-17 | 9.6 |
| 17-18 | 12.5 |
| 18-19 | 11.9 |
| 19-20 | 8.3 |
| 20-21 | 4.9 |
Depth Chart
Depth Chart
PHX — all five positions, best player first at each spot.
C
—
PF
—
SF
—
SG
—
PG
E'Twaun Moore
Season History
9-categoryNBA profile
| SeasonNBA season | AgeAge during the season | TeamTeam | GPGames played | GSGames started | MPGMinutes per game | RankOverall fantasy rank (averages) | ValueFantasy ranking value (averages) | PTSPoints per game | REBRebounds per game | ASTAssists per game | STLSteals per game | BLKBlocks per game | 3PMThree-pointers made per game | FG%Field goal percentage | FGAField goal attempts per game | FT%Free throw percentage | FTAFree throw attempts per game | TOTurnovers per game |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20-21 | 32 | PHX | 27 | 0 | 14.4 | #359 | -3.91 | 4.9 | 1.7 | 1.5 | 0.6 | 0.2 | 0.4 | 45.5% | 4.5 | 85.7% | 0.5 | 0.9 |
| 19-20 | 31 | NOP | 56 | 0 | 18.2 | #303 | -2.60 | 8.3 | 2.3 | 1.4 | 0.6 | 0.2 | 1.1 | 42.6% | 7.8 | 68.9% | 0.8 | 0.7 |
| 18-19 | 30 | NOP | 53 | 0 | 27.6 | #174 | 0.14 | 11.9 | 2.4 | 1.9 | 0.8 | 0.2 | 1.4 | 48.1% | 10 | 76.3% | 1.1 | 1.1 |
| 17-18 | 29 | NOP | 82 | 0 | 31.5 | #110 | 1.65 | 12.5 | 2.9 | 2.3 | 1 | 0.1 | 1.6 | 50.8% | 10.1 | 70.6% | 0.8 | 1.2 |
| 16-17 | 28 | NOP | 73 | 0 | 24.9 | #170 | -0.17 | 9.6 | 2.1 | 2.2 | 0.7 | 0.4 | 1.1 | 45.7% | 8.5 | 77.0% | 1 | 0.8 |
| 15-16 | 27 | CHI | 59 | 0 | 21.4 | #222 | -1.33 | 7.5 | 2.3 | 1.7 | 0.6 | 0.3 | 0.8 | 48.1% | 6.6 | 62.9% | 0.6 | 0.9 |
| 14-15 | 26 | CHI | 56 | 0 | 9 | n/a | n/a | 2.7 | 0.8 | 0.6 | 0.4 | 0.1 | 0.2 | 44.6% | 2.5 | 60.0% | 0.4 | 0.3 |
| 13-14 | 25 | ORL | 79 | 0 | 19.1 | #246 | -1.94 | 6.3 | 1.7 | 1.4 | 0.8 | 0.2 | 0.7 | 42.8% | 5.8 | 76.5% | 0.9 | 0.7 |
| 12-13 | 24 | ORL | 75 | 0 | 22.4 | #246 | -1.86 | 7.8 | 2.2 | 2.7 | 0.7 | 0.3 | 0.9 | 39.6% | 8 | 79.7% | 0.8 | 1.4 |
| 11-12 | 23 | BOS | 38 | 0 | 8.7 | n/a | n/a | 2.9 | 0.9 | 0.9 | 0.3 | 0.1 | 0.4 | 38.1% | 3 | 100.0% | 0.2 | 0.6 |